Cytokine Release Syndrome (crs) - Histology

Relevant Publications

Dermatologic adverse events associated with chimeric antigen receptor T-cell therapy: a pharmacovigilance analysis of the FDA reporting system.

Issue Release: 2024

First-in-human clinical trial results with ABBV-184, a first-in-class T-cell Receptor/Anti-CD3 bispecific protein, in adults with Previously treated AML or NSCLC.

Issue Release: 2024

Cytokine release syndrome following durvalumab and tremelimumab in advanced hepatocellular carcinoma: A case report with cytokine and damage-associated molecular pattern analysis.

Issue Release: 2024

Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide.

Issue Release: 2024

Matching-adjusted indirect comparisons of axicabtagene ciloleucel to mosunetuzumab for the treatment of relapsed/refractory follicular lymphoma.

Issue Release: 2024

Hemophagocytic Lymphohistiocytosis in the Context of Hematological Malignancies and Solid Tumors.

Issue Release: 2024

IL-6 Blockade in Cytokine Storm Syndromes.

Issue Release: 2024

Safety and clinical activity of JNJ-78306358, a human leukocyte antigen-G (HLA-G) x CD3 bispecific antibody, for the treatment of advanced stage solid tumors.

Issue Release: 2024

Optimization Strategies in CAR T-cell Therapy: A Comprehensive Evaluation of Cytopenia, HLH/MAS, and Other Adverse Events.

Issue Release: 2024

Advances in CAR-NK cell therapy for lung cancer: is it a better choice in the future?

Issue Release: 2024

S309-CAR-NK cells bind the Omicron variants and reduce SARS-CoV-2 viral loads in humanized ACE2-NSG mice.

Issue Release: 2024

Acute kidney injury after CAR-T cell therapy: exploring clinical patterns, management, and outcomes.

Issue Release: 2024

An Early Neurological Indicator of Immune Effector Cell-Associated Neurotoxicity Syndrome.

Issue Release: 2024

Change in Neurocognitive Function in Patients Who Receive CAR-T Cell Therapies: A Steep Hill to Climb.

Issue Release: 2024

Population pharmacokinetics and CD20 binding dynamics for mosunetuzumab in relapsed/refractory B-cell non-Hodgkin lymphoma.

Issue Release: 2024

Genetic Susceptibility in Endothelial Injury Syndromes after Hematopoietic Cell Transplantation and Other Cellular Therapies: Climbing a Steep Hill.

Issue Release: 2024

Safety and tolerability of AMG 330 in adults with relapsed/refractory AML: a phase 1a dose-escalation study.

Issue Release: 2024

The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide.

Issue Release: 2024

Very unusual extremely high ferritin with cytokine release syndrome in a patient with hematological malignancy after experimental chimeric antigen receptor (CAR)-T-Cell therapy.

Issue Release: 2024

What is the Importance of Histopathology in Medicine?

What is the Difference Between Healing by Primary and Secondary Intention?

How is Apoptosis Resistance Studied in Histology?

How Does the Canonical Wnt Pathway Work?

What are the Key Organelles in Mammalian Cells?

How is Goblet Cell Hyperplasia Diagnosed?

How Do Feedback Mechanisms Work?

What is the Structure of Intercalated Discs?

How Do Cells Interact Within Tissue Architecture?

How to Store a Microscope Correctly?

Cytokine Release Syndrome (crs) - Histology

Relevant Publications

Partnered Content Networks

Relevant Topics